Diamond Biotechnology Co., Ltd (TPEX:6815)

Diamond Biotechnology Statistics

Total Valuation

TPEX:6815 has a market cap or net worth of TWD 1.21 billion. The enterprise value is 1.20 billion.

Market Cap	1.21B
Enterprise Value	1.20B

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026.

Earnings Date	May 13, 2026
Ex-Dividend Date	Aug 27, 2025

Share Statistics

TPEX:6815 has 39.74 million shares outstanding. The number of shares has increased by 2.00% in one year.

Current Share Class	39.74M
Shares Outstanding	39.74M
Shares Change (YoY)	+2.00%
Shares Change (QoQ)	-1.53%
Owned by Insiders (%)	11.21%
Owned by Institutions (%)	n/a
Float	22.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.41
PB Ratio	2.23
P/TBV Ratio	2.23
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-17.01
EV / Sales	2.39
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-412.96

Financial Position

The company has a current ratio of 3.28, with a Debt / Equity ratio of 0.37.

Current Ratio	3.28
Quick Ratio	2.16
Debt / Equity	0.37
Debt / EBITDA	n/a
Debt / FCF	-68.32
Interest Coverage	-16.56

Financial Efficiency

Return on equity (ROE) is -12.07% and return on invested capital (ROIC) is -16.21%.

Return on Equity (ROE)	-12.07%
Return on Assets (ROA)	-5.58%
Return on Invested Capital (ROIC)	-16.21%
Return on Capital Employed (ROCE)	-11.99%
Weighted Average Cost of Capital (WACC)	5.80%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.52
Inventory Turnover	3.07

Taxes

Income Tax	-9.53M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.42% in the last 52 weeks. The beta is 0.39, so TPEX:6815's price volatility has been lower than the market average.

Beta (5Y)	0.39
52-Week Price Change	-37.42%
50-Day Moving Average	41.15
200-Day Moving Average	53.42
Relative Strength Index (RSI)	32.65
Average Volume (20 Days)	151,949

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6815 had revenue of TWD 501.49 million and -70.31 million in losses. Loss per share was -1.78.

Revenue	501.49M
Gross Profit	155.25M
Operating Income	-85.93M
Pretax Income	-79.84M
Net Income	-70.31M
EBITDA	-57.21M
EBIT	-85.93M
Loss Per Share	-1.78

Balance Sheet

The company has 209.76 million in cash and 197.91 million in debt, with a net cash position of 11.85 million or 0.30 per share.

Cash & Cash Equivalents	209.76M
Total Debt	197.91M
Net Cash	11.85M
Net Cash Per Share	0.30
Equity (Book Value)	541.83M
Book Value Per Share	13.71
Working Capital	347.04M

Cash Flow

In the last 12 months, operating cash flow was -2.09 million and capital expenditures -812,000, giving a free cash flow of -2.90 million.

Operating Cash Flow	-2.09M
Capital Expenditures	-812,000
Depreciation & Amortization	28.72M
Net Borrowing	-22.03M
Free Cash Flow	-2.90M
FCF Per Share	-0.07

Margins

Gross margin is 30.96%, with operating and profit margins of -17.13% and -14.02%.

Gross Margin	30.96%
Operating Margin	-17.13%
Pretax Margin	-15.92%
Profit Margin	-14.02%
EBITDA Margin	-11.41%
EBIT Margin	-17.13%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.17, which amounts to a dividend yield of 0.55%.

Dividend Per Share	0.17
Dividend Yield	0.55%
Dividend Growth (YoY)	39.78%
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	-2.00%
Shareholder Yield	-1.45%
Earnings Yield	-5.82%
FCF Yield	-0.24%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 27, 2025. It was a forward split with a ratio of 1.17601694.

Last Split Date	Aug 27, 2025
Split Type	Forward
Split Ratio	1.17601694

Scores

Altman Z-Score	n/a
Piotroski F-Score	2